SG11201406495UA - Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent - Google Patents
Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agentInfo
- Publication number
- SG11201406495UA SG11201406495UA SG11201406495UA SG11201406495UA SG11201406495UA SG 11201406495U A SG11201406495U A SG 11201406495UA SG 11201406495U A SG11201406495U A SG 11201406495UA SG 11201406495U A SG11201406495U A SG 11201406495UA SG 11201406495U A SG11201406495U A SG 11201406495UA
- Authority
- SG
- Singapore
- Prior art keywords
- halofenate
- gout
- patients
- inflammatory agent
- treating hyperuricemia
- Prior art date
Links
- BJBCSGQLZQGGIQ-UHFFFAOYSA-N 2-acetamidoethyl 2-(4-chlorophenyl)-2-[3-(trifluoromethyl)phenoxy]acetate Chemical compound C=1C=C(Cl)C=CC=1C(C(=O)OCCNC(=O)C)OC1=CC=CC(C(F)(F)F)=C1 BJBCSGQLZQGGIQ-UHFFFAOYSA-N 0.000 title 1
- 201000005569 Gout Diseases 0.000 title 1
- 201000001431 Hyperuricemia Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 229950000958 halofenate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261624186P | 2012-04-13 | 2012-04-13 | |
| PCT/US2013/036474 WO2013155478A1 (en) | 2012-04-13 | 2013-04-12 | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406495UA true SG11201406495UA (en) | 2014-11-27 |
Family
ID=49325641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406495UA SG11201406495UA (en) | 2012-04-13 | 2013-04-12 | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent |
Country Status (15)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6356684B2 (ja) | 2012-11-02 | 2018-07-11 | マレイ・アンド・プール・エンタープライゼズ・リミテッド | コルヒチン誘導体の投与による心血管イベントの処置または予防 |
| MY207496A (en) | 2013-04-16 | 2025-02-28 | Murray And Poole Enterprises Ltd | Sustained-release formulations of colchicine and methods of using same |
| US9907751B2 (en) | 2016-03-10 | 2018-03-06 | RxOMEG Therapeutics LLC | Composition and method of use of colchicine oral liquid |
| JP2023035118A (ja) * | 2021-08-31 | 2023-03-13 | 国立大学法人広島大学 | 体液サンプリング容器 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| US7576131B2 (en) * | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| RU2501555C2 (ru) * | 2008-03-13 | 2013-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения и способ снижения мочевой кислоты |
| WO2009114784A1 (en) * | 2008-03-14 | 2009-09-17 | Intelliherb, Llc | Licorice lollipop that inhibits dental caries formation |
| US20100137235A1 (en) * | 2008-10-15 | 2010-06-03 | Mutual Pharmaceutical Company, Inc. | Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| US9060987B2 (en) * | 2011-11-04 | 2015-06-23 | Cymabay Therapeutics, Inc. | Methods for treating gout flares |
| MX357507B (es) * | 2011-11-04 | 2018-07-12 | Cymabay Therapeutics Inc | Metodos para tratar hiperucemia en pacientes con gota utilizando halofenato o acido halofenico y un segundo agente de reduccion de urato. |
| BR112014010693A2 (pt) * | 2011-11-04 | 2020-11-10 | Cymabay Therapeutics, Inc. | uso de um composto para a preparação de uma composição farmacêutica para o tratamento de gota em subpopulações de pacientes |
| CN104066324A (zh) * | 2011-11-04 | 2014-09-24 | 西玛贝医药公司 | 治疗痛风急性发作的方法 |
-
2013
- 2013-04-12 CN CN201380030570.9A patent/CN104602686A/zh active Pending
- 2013-04-12 MX MX2014012376A patent/MX2014012376A/es unknown
- 2013-04-12 AU AU2013245675A patent/AU2013245675B2/en not_active Ceased
- 2013-04-12 EP EP13776027.8A patent/EP2836209A4/en not_active Withdrawn
- 2013-04-12 WO PCT/US2013/036474 patent/WO2013155478A1/en active Application Filing
- 2013-04-12 CA CA2870014A patent/CA2870014A1/en not_active Abandoned
- 2013-04-12 JP JP2015505961A patent/JP2015512948A/ja active Pending
- 2013-04-12 HK HK15103663.3A patent/HK1204913A1/xx unknown
- 2013-04-12 US US13/862,262 patent/US20130274331A1/en not_active Abandoned
- 2013-04-12 SG SG11201406495UA patent/SG11201406495UA/en unknown
- 2013-04-12 KR KR20147031687A patent/KR20150002799A/ko not_active Withdrawn
- 2013-04-12 EA EA201491870A patent/EA028495B1/ru not_active IP Right Cessation
-
2014
- 2014-10-10 CL CL2014002728A patent/CL2014002728A1/es unknown
- 2014-10-10 PH PH12014502282A patent/PH12014502282A1/en unknown
- 2014-10-19 IL IL235154A patent/IL235154A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2870014A1 (en) | 2013-10-17 |
| HK1204913A1 (en) | 2015-12-11 |
| CL2014002728A1 (es) | 2015-06-19 |
| AU2013245675A1 (en) | 2014-10-30 |
| PH12014502282A1 (en) | 2014-12-15 |
| EA201491870A1 (ru) | 2015-03-31 |
| WO2013155478A1 (en) | 2013-10-17 |
| EA028495B1 (ru) | 2017-11-30 |
| IL235154A0 (en) | 2014-12-31 |
| JP2015512948A (ja) | 2015-04-30 |
| AU2013245675B2 (en) | 2017-02-09 |
| KR20150002799A (ko) | 2015-01-07 |
| MX2014012376A (es) | 2015-06-05 |
| EP2836209A1 (en) | 2015-02-18 |
| US20130274331A1 (en) | 2013-10-17 |
| CN104602686A (zh) | 2015-05-06 |
| EP2836209A4 (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2627368B8 (de) | Verfahren und vorrichtung zur messung und behebung von systemänderungen in einer vorrichtung zur behandlung von blut | |
| SG11201401189WA (en) | Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection | |
| EP2627331A4 (en) | METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES | |
| EP2788075A4 (en) | DEVICE AND METHOD FOR REDUCING THE TRANSTHORACOID IMPEDANCE OF A PATIENT | |
| GB2504861B8 (en) | Electrophoretic mobility measurement cell and measurement apparatus and method using the same | |
| ZA201300055B (en) | Treatment of gout and hyperuricemia | |
| EP2613735A4 (en) | DEVICES AND METHODS FOR THE TREATMENT OF VASCULAR ABNORMALITIES | |
| SG11201401811WA (en) | Method for preventing and/or treating insulin resistance | |
| IL226352A0 (en) | שקיטה@לטיפול@עם@מעקב@braf | |
| FI20115893L (fi) | Menetelmä retention säätämiseksi ja menetelmässä käytettävä välituote | |
| EP2865409A4 (en) | NEEDLE-BODY BODY AND MANUFACTURING METHOD FOR NEEDLE-BODY BODY | |
| PL2815769T3 (pl) | FAM19A5 do zastosowania w diagnostyce i leczeniu uszkodzeń OUN | |
| PT2663864T (pt) | Método de avaliação de imunodiversidade e seu uso | |
| EP2739352A4 (en) | MULTIMODAL ELECTROTHERAPY PROCESS AND DEVICE | |
| PL2613798T5 (pl) | Zastosowanie lizosomalnej kwaśnej lipazy do leczenia niedoboru lizosomalnej kwaśnej lipazy u pacjentów | |
| SG10201401598RA (en) | Anaerobic treatment method and apparatus | |
| EP2867239A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES | |
| IL232384A0 (en) | Use of preparations containing halofanate or halophanic acid to treat gout | |
| EP2922536A4 (en) | USE OF BUCILLAMINE IN THE TREATMENT OF GOUTTE | |
| ZA201403575B (en) | Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent | |
| EP2929835A4 (en) | DEVICE FOR MEASURING THE COMPOSITION OF A BODY, METHOD FOR MEASURING THE COMPOSITION OF A BODY AND METHOD FOR CORRECTING THE MEASUREMENT OF THE COMPOSITION OF A BODY | |
| DK3434276T3 (da) | Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft | |
| ZA201304353B (en) | Remedial composition and treatment methods | |
| SG11201406495UA (en) | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent | |
| PT2630475T (pt) | Método de diagnóstico e tratamento |